The U.S. Food and Drug Administration first approved mifepristone in 2000, and the drug has since become the most common method of abortion in the United States, accounting for 65% of all U.S. abortions in 2023

From the articleFDA says its review of abortion pill will continue into next yearAlso in Abortion drug safety review will be completed by March, US FDA says | Reuters, FDA's abortion pill safety review continuing into next year angers abortion rights opponents, FDA says its safety review of abortion pill will continue into next year | CNN, FDA says it will complete safety review of abortion pill in March, FDA says its review of abortion pill will continue into next year